首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Medicine >Effects of PPARα/PGC-1α on the myocardial energy metabolism during heart failure in the doxorubicin induced dilated cardiomyopathy in mice
【2h】

Effects of PPARα/PGC-1α on the myocardial energy metabolism during heart failure in the doxorubicin induced dilated cardiomyopathy in mice

机译:PPARα/PGC-1α对阿霉素诱发的扩张型心肌病小鼠心力衰竭期间心肌能量代谢的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: This study aims to investigate the effects and their mechanisms of PPARα and PGC-1α pathways in doxorubicin induced dilated cardiomyopathy in mice. Methods: The model of dilated cardiomyopathy (DCM) was established by injecting doxorubicin in mice. The 40 surviving mice were divided randomly into control group, doxorubicin model group, PPARα inhibitor and PPARα agonist group. The PPARα/PGC-1α proteins were detected. The size of adenine acid pool (ATP, ADP, AMP) and phosphocreatine (Pcr) in mitochondria were measured by HPLC. The ANT activity was detected by the atractyloside-inhibitor stop technique. The echocardiography and hemodynamic changes were detected in each group after PPARα inhibitor and PPARα agonist treatment for 2 weeks. Results: The DOX induced DCM model were successfully established. The expression of PPARα and PGC-1α protein level in normal group were significantly higher than that in DOX model group (P<0.05). Both the high-energy phosphate content and the transport activity of ANT were decreased in DOX group (P<0.05), and the hemodynamic parameters were disorder (P<0.01). Compared with Dox group, PPARα inhibitor intervention significantly reduce the expression of PPARα/PGC-1α, high-energy phosphate content in the mitochondria had no significant change (P>0.05), but the ANT transport activity of mitochondria decreased significantly (P<0.05), the left ventricular function decreased. On the other side, PPARα agonist intervention significantly increased the expression of PPARα and PGC-1α, improved transport activity of ANT, the hemodynamic parameters was ameliorated (P<0.05), but the high-energy phosphate content of mitochondria did not change significantly (P>0.05). Conclusion: There was lower expression of PPARα and PGC-1α in DOC induced DCM in mice. Promotion of PPARα can improve myocardia energy metabolism and delay the occurrence of heart failure.
机译:目的:本研究旨在探讨PPARα和PGC-1α途径在阿霉素诱导的小鼠扩张性心肌病中的作用及其机制。方法:通过在小鼠体内注射阿霉素建立扩张型心肌病(DCM)模型。将40只存活的小鼠随机分为对照组,阿霉素模型组,PPARα抑制剂和PPARα激动剂组。检测到PPARα/PGC-1α蛋白。通过HPLC测量线粒体中腺嘌呤酸池(ATP,ADP,AMP)和磷酸肌酸(Pcr)的大小。通过白术苷抑制剂终止技术检测ANT活性。 PPARα抑制剂和PPARα激动剂治疗2周后,各组均进行超声心动图检查和血流动力学变化。结果:成功建立了DOX诱导的DCM模型。正常组PPARα和PGC-1α蛋白表达明显高于DOX模型组(P <0.05)。 DOX组高能磷酸盐含量和ANT的转运活性均下降(P <0.05),血液动力学参数紊乱(P <0.01)。与Dox组相比,PPARα抑制剂干预显着降低PPARα/PGC-1α的表达,线粒体中高能磷酸盐含量无明显变化(P> 0.05),但线粒体的ANT转运活性明显降低(P <0.05 ),左心室功能下降。另一方面,PPARα激动剂干预显着增加了PPARα和PGC-1α的表达,改善了ANT的转运活性,改善了血流动力学参数(P <0.05),但线粒体的高能磷酸盐含量没有明显变化(P <0.05)。 P> 0.05)。结论:DOC诱导的DCM中PPARα和PGC-1α的表达较低。促进PPARα可以改善心肌能量代谢并延迟心力衰竭的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号